Clinical trials
Phase 1/2 Neoplasms, Germ Cell and Embryonal trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2017 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 4 |
| Completed | 3 |
| Unknown status | 3 |
| Not yet recruiting | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 2 |
| National Cancer Institute (NCI) | 2 |
| Ann & Robert H Lurie Children's Hospital of Chicago | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| CHA University | 1 |
| Hoffmann-La Roche | 1 |
| Indiana University | 1 |
| Nationwide Children's Hospital | 1 |
| OHSU Knight Cancer Institute | 1 |
| St. Jude Children's Research Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms, Germ Cell and Embryonal | 13 |
| Sarcoma | 4 |
| Lung Neoplasms | 3 |
| Adenocarcinoma | 2 |
| Bronchial Neoplasms | 2 |
| Carcinoma | 2 |
| Carcinoma, Bronchogenic | 2 |
| Carcinoma, Neuroendocrine | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Central Nervous System Neoplasms | 2 |
Trials
Showing 51 to 13 of 13. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.